CCX354-C
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCX354-C, covering 2025-03-06 to 2025-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy [Phase 2]